InvestorsHub Logo
Followers 2
Posts 429
Boards Moderated 0
Alias Born 07/13/2016

Re: Samsa post# 31921

Monday, 12/18/2017 12:28:51 PM

Monday, December 18, 2017 12:28:51 PM

Post# of 38634
Due to the suspect data coming from Symphony, the trend is probably the best thing that comes from the data. Also, I have been posting sales numbers assuming the list price of the drug is the real price. But there are discounts involved that lower those revenues. There is another option called "manufacturers benchmark sales" that I beleive tries to account for those discounts. Perhaps I should try posting that from now on.

The key issue for IPCI right now is not sales but cash. How much do they have? How much will they raise? When will they raise it? Will they get it from a partnership deal instead of an equity raise? Sales from Seroquel and Focalin just are not going to be enough to fund the company going forward.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y